Camurus AB (CAMRF) reports a 52% revenue increase, strategic licensing with Eli Lilly, and EU approval of Oczyesa, despite currency challenges and market hurdles.

Tim Fabbri went 2-for-3 with four RBIs to lead Lilly Conrad Chiropractic to a 17-5 five-inning win over Sheetz Thursday in ...

The list of lucky recipients includes Stanley Kalu, Jennifer Reeder, Marco Bermudez, K. Broch, Quincy Cho, Jacy Duan, Sydney ...

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...

Courtney Roberts, a seasoned nonprofit leader, has been named president and CEO of Riley Children's Foundation, a foundation dedicated to supporting children's health.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

The Food and Drug Administration has authorized Juul's original vaporizer and flavored cartridges to remain on the U.S.

The sale represents Clever Culture’s fifth engagement with a leading pharma manufacturer, including AstraZeneca, Bristol Myers Squibb and Thermo Fisher. The company is due to report its Q4 FY25 ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

While Leerink still expects Zoetis to post revenue and earnings growth, it sees the pace decelerating as rivals like Elanco and Merck (NSE: PROR) gain share. The firm forecasts Zoetis EPS growth to ...

Mega-Cap Movers (Market Cap $200B+): Large-Cap Stock Movers (Market Cap $10B-$200B): New Providence Acquisition Corp N (ASTS): +8.77% CoreWeave (CRWV): CoreWeave stock initiated with Reduce rating by ...